Latest news
Loading news…
Prexton Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Plan-les-ouates, Geneve, Switzerland Founded 2012 1-10 employees For Profit
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life.
Prexton Therapeutics was acquired by Lundbeck in 2018 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Active products
- 3
- Patents granted
- 3
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $133K
Company Info
- Founded
- 2012
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 15
- HQ
- Plan-les-ouates, Geneve, Switzerland
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Mar 16, 2018
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.1
- Trend (90d)
- -0.2
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Prexton Therapeutics
Loading news…
FAQs about Prexton Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.